In this section you will find a comprehensive list of all the meetings that the FDA is involved with. The meetings may include advisory committee meetings, public workshops and public conferences that are seeking to hear from patients and caregivers.
Most FDA meetings are free to the public and do not require the public to register. Interested persons may present data, information, or views, orally at the meeting, or in writing, on issues pending before the committee. Other types of meetings listed may require prior registration and fees.
|
Public Meeting: Patient-Focused Drug Development Public Meeting for Sarcopenia
Date: April 6, 2017
Time: 1:00 p.m. - 5:00 p.m.
Location: FDA White Oak Campus, 10903 New Hampshire Ave.
Building 31, Room 1503 B and C (Great Room), Silver Spring, MD 20993
Time: 1:00 p.m. - 5:00 p.m.
Location: FDA White Oak Campus, 10903 New Hampshire Ave.
Building 31, Room 1503 B and C (Great Room), Silver Spring, MD 20993
Agenda: FDA is interested in obtaining patient perspectives on the on the impact of sarcopenia on daily life and patient views on treatment approaches.
Registration: To register for this meeting, visit: Patient-Focused Drug Development Public Meeting for Sarcopenia Event Brite website.
Registration to attend the meeting must be received by March 27, 2017.
View FDA's Patient Network Calendar of Public Meetings page for a complete list of meetings and workshops.
For additional information on other agency meetings please visit Meetings, Conferences, & Workshops.
|
No hay comentarios:
Publicar un comentario